Can’t find what you’re looking for? Just contact us and we’ll get back to you.
Empower your organization with a suite of forecasting tools designed to enhance decision-making and refine your commercial strategy.
Discover >
Streamline your business development and licensing strategies with actionable insights and informed decision making, supported by gold-standard data.
Enhance asset management with powerful tools that enable data-driven decisions and optimize your portfolio strategy for sustainable growth.
Stay ahead of the competition by leveraging competitive intelligence solutions to monitor market trends, anticipate competitor actions, and make strategic data-driven decisions.
Evaluate gives medical communications teams the market, pipeline and competitive intelligence they need to understand complex therapy areas, develop relevant communications strategies, and support clients with greater confidence.
Evaluate gives consulting teams the trusted market intelligence they need to answer difficult client questions, develop evidence-backed strategies, and deliver recommendations that stand up to scrutiny.
Build sharper valuation narratives for pharma and biotech M&A, IPOs and capital raising with trusted market data, forecasts, and evidence-backed insight.
Screen emerging pharma and biotech opportunities, assess asset potential, and track the market signals that could shape portfolio growth.
Assess pharma and biotech targets, pressure-test commercial assumptions, and support diligence with trusted market, product and competitor intelligence.
Track catalysts, forecast revisions, regulatory events, and competitive shifts that could affect pharma and biotech company valuations.
Explore Evaluate’s modular portfolio of pharma and biotech datasets, from product and indication sales to PTRS, deals and company financials.
See what sets Evaluate data apart, from proprietary forecasting methodology to indication-level depth and specialist analyst input.
Bring Evaluate data into your existing systems through Snowflake, structured data feeds, selected APIs and MCP integrations.
License expert-curated pharma and biotech data for approved AI applications, models and internal workflows.
Designing Pharmaceutical Forecast Models That Actually Work
Market Trends, Pipeline Evolution & Future Growth Drivers in Oncology
World Preview 2026: Big Drugs. Bigger Questions.
Introducing the Pipeline-to-Patient Productivity Index (P3i)
Webinar
Registration Open
The Drug Launches That Will Shape 2027
12 November | 3pm GMT | 10am ET
Take a look at our past webinars, all available on demand.
September 23, 2026
Reading the Signals
Applying Pharma Productivity Benchmarks to Internal CI Programs
September 9, 2026
May 15, 2026
China Pipelines, Western Portfolios
ASCO 2026: Key Insights and Innovations
April 2, 2026
World Preview 2026 Webinar
March 12, 2026
Unlock Strategic Insights for Pharma: Custom Competitive Intelligence and Landscape Monitoring
February 17, 2026
Orphan Drugs: A safe(r) passage amid stormy waters?
December 18, 2025
Unlock the Secrets to Long Range Planning Success
December 1, 2025
Inside #JPM2026: The Stories Behind the Summit
To use this booking feature you need to accept all cookies. Please update your preferences to continue.
